Literature DB >> 18695939

Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways.

J Tang1, Y-M Wu, P Zhao, X-M Yang, J-L Jiang, Z-N Chen.   

Abstract

Mechanism of HAb18G/CD147 underlying the metastasis process of human hepatoma cells has not been determined. In the present study, we found that integrin alpha3beta1 colocalizes with HAb18G/CD147 in human 7721 hepatoma cells. The enhancing effect of HAb18G/CD147 on adhesion, invasion capacities and matrix metalloproteinases (MMPs) secretion was decreased by integrin alpha3beta1 antibodies (p<0.01). The expressions of integrin downstream molecules including focal adhesion kinase (FAK), phospho-FAK (p-FAK), paxillin, and phospho-paxillin (p-paxillin) were increased in human hepatoma cells overexpressing HAb18G/CD147. Deletion of HAb18G/CD147 reduces the quantity of focal adhesions and rearranges cytoskeleton. Wortmannin and LY294002, specific phosphatidylinositol kinase (PI3K) inhibitors, reversed the effect of HAb18G/CD147 on the regulation of intracellular Ca(2+) mobilization, significantly reducing cell adhesion, invasion and MMPs secretion potential (p<0.01). Together, these results suggest that HAb18G/CD147 enhances the invasion and metastatic potentials of human hepatoma cells via integrin alpha3beta1-mediated FAK-paxillin and FAKPI3K-Ca(2+) signal pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695939      PMCID: PMC7079791          DOI: 10.1007/s00018-008-8315-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  45 in total

1.  CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma.

Authors:  J Tang; Y-S Guo; Y Zhang; X-L Yu; L Li; W Huang; Y Li; B Chen; J-L Jiang; Z-N Chen
Journal:  Cell Death Differ       Date:  2012-05-18       Impact factor: 15.828

2.  Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.

Authors:  Shaojun Zhu; Yanhong Li; Li Mi; Yang Zhang; Li Zhang; Li Gong; Xiujuan Han; Li Yao; Miao Lan; Zhinan Chen; Wei Zhang
Journal:  Dig Dis Sci       Date:  2011-07-26       Impact factor: 3.199

3.  Regulation of invadopodia formation and activity by CD147.

Authors:  G Daniel Grass; Momka Bratoeva; Bryan P Toole
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

4.  Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.

Authors:  Yong Li; Jiao Wu; Fei Song; Juan Tang; Shi-Jie Wang; Xiao-Ling Yu; Zhi-Nan Chen; Jian-Li Jiang
Journal:  J Biol Chem       Date:  2011-11-30       Impact factor: 5.157

5.  EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2.

Authors:  S Sangboonruang; P Thammasit; N Intasai; W Kasinrerk; C Tayapiwatana; K Tragoolpua
Journal:  Cancer Gene Ther       Date:  2014-06-13       Impact factor: 5.987

6.  A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway.

Authors:  Yuan Wang; Lin Yuan; Xiang-Min Yang; Ding Wei; Bin Wang; Xiu-Xuan Sun; Fei Feng; Gang Nan; Ye Wang; Zhi-Nan Chen; Huijie Bian
Journal:  Clin Exp Metastasis       Date:  2014-11-26       Impact factor: 5.150

7.  CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells.

Authors:  Shaoxing Yang; Fei Qi; Chuanhao Tang; Hong Wang; Haifeng Qin; Xiaoyan Li; Jianjie Li; Weixia Wang; Changyun Zhao; Hongjun Gao
Journal:  Oncol Lett       Date:  2016-12-14       Impact factor: 2.967

8.  HAb18G/CD147 cell-cell contacts confer resistance of a HEK293 subpopulation to anoikis in an E-cadherin-dependent manner.

Authors:  Xiao-Kui Ma; Li Wang; Yu Li; Xiang-Ming Yang; Pu Zhao; Ping Zhu; Ling Li; Zhi-Nan Chen
Journal:  BMC Cell Biol       Date:  2010-04-17       Impact factor: 4.241

9.  Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones.

Authors:  Yue-Hu Han; Bo Gao; Jing-Hui Huang; Zhen Wang; Zheng Guo; Qiang Jie; Liu Yang; Zhuo-Jing Luo
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

10.  The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells.

Authors:  Jing-yao Dai; Ke-feng Dou; Cong-hua Wang; Pu Zhao; Wayne Bond Lau; Ling Tao; Ya-mei Wu; Juan Tang; Jian-li Jiang; Zhi-nan Chen
Journal:  BMC Cancer       Date:  2009-09-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.